Company
Contineum Therapeutics
Contineum Therapeutics has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| PIPE-791 Dose A | Phase 2 | Idiopathic Pulmonary Fibrosis |
Latest
No recent events.
Follow Contineum Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.